UC Davis Health’s Tiffany Phung, Pharm.D., and Tim Cutler, Pharm.D., say staff-driven ideas protect research independence in industry partnerships.
|Articles|October 14, 2015
AMCP president identifies top managed care pharmacy challenges
Author(s)Aubrey Westgate
Raulo Frear, AMCP president, discusses the upcoming AMCP conference and some of the top challenges and opportunities facing the managed care pharmacy industry. Read more.
Advertisement
With the Academy of Managed Care Pharmacy Conference (AMCP) Nexus 2015 just around the corner, Managed Healthcare Executive sat down with Raulo Frear, AMCP president, to discuss the conference and some of the challenges and opportunities facing the managed care pharmacy industry today.
Click below to listen to the podcast.
To view more conference coverage, visit our
Advertisement
Related to this article
UC Davis Health’s Tiffany Phung, Pharm.D., and Tim Cutler, Pharm.D., say research justifies services and opens doors to limited distribution drugs.
As the pharmacist pipeline tightens, leaders from UC Davis Health, UCSF Health, and Sutter Health say financial sustainability now depends as much on capacity as on cost.
AI analyzes single-lead ECGs from sleep studies to predict atrial fibrillation, heart failure, and mortality risk, enabling scalable cardiovascular disease screening.
Consistent bedtime routines, screen-free bedrooms and therapist support for night waking help children with ADHD sleep better, said Alison Pritchard, Ph.D.
Jamilia Sherls, DNP, MPH, RN, CPN, CDP, of Washington’s health department says health systems should look to AAP and AAFP schedules and build on patients’ trust in providers.
Jamilia Sherls, DNP, MPH, RN, CPN, CDP, of Washington’s health department says a stayed schedule overhaul cutting recommended child vaccines from 17 to 11 could upend coverage.
The American College of Chest Physicians and the European Respiratory Society issued bronchiectasis guidelines recently. Here is a comparison.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Apothecary Pharma recalls compounded tirzepatide and NAD+ vials over sterility concerns
2
For bronchiectasis, a new era of guideline-guided care | CHEST 2026
3
Now is the time to get ready for 2027 changes in prior authorization, MA Star Ratings and others in federal healthcare law and regulations
4
Jessica Castle, M.D., discusses CGM’s A1C impact in non-insulin type 2 diabetes
5